MV Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440 | Sell |
8
-2
| -20% | -$110 | ﹤0.01% | 866 |
|
|
2025
Q1 | $707 | Sell |
10
-60
| -86% | -$4.24K | ﹤0.01% | 788 |
|
|
2024
Q4 | $4.6K | Buy |
70
+62
| +775% | +$4.08K | ﹤0.01% | 615 |
|
|
2024
Q3 | $563 | Sell |
8
-2
| -20% | -$141 | ﹤0.01% | 796 |
|
|
2024
Q2 | $824 | Buy |
10
+5
| +100% | +$412 | ﹤0.01% | 705 |
|
|
2024
Q1 | $437 | Buy |
5
+1
| +25% | +$87 | ﹤0.01% | 710 |
|
|
2023
Q4 | $386 | Buy |
+4
| New | +$386 | ﹤0.01% | 690 |
|
|
2018
Q2 | – | Sell |
-500
| Closed | -$41K | – | 356 |
|
|
2018
Q1 | $41K | Buy |
+500
| New | +$41K | 0.01% | 168 |
|